| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.5M | -92.0% |
| R&D Expense | $330.1M | +37.1% |
| SG&A Expense | $173.6M | -2.5% |
| Operating Income | -$496.2M | -53.1% |
| Interest Expense | $28.3M | +45.8% |
| Income Tax | $0 | — |
| Net Income | -$526.2M | -35.3% |
| EPS (Basic) | -$5.45 | -25.9% |
| EPS (Diluted) | -$5.45 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $113.0M | +72.3% |
| Accounts Receivable | $1.3M | +772.8% |
| Current Assets | $628.1M | -21.0% |
| Total Assets | $824.3M | -18.8% |
| Current Liabilities | $102.7M | +21.3% |
| Long-term Debt | $639.3M | -1.6% |
| Total Liabilities | $1.21B | +7.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$414.3M | -38.3% |
| Capital Expenditures | $1.4M | -87.5% |
| Investing Cash Flow | $239.3M | +191.3% |
| Financing Cash Flow | $221.3M | -57.1% |
| Free Cash Flow | -$415.7M | -33.7% |
| -25.9% |
| Stockholders' Equity |
| -$386.3M |
| -258.0% |